Because the expression of PD-1 on Tregs has a critical role in maintaining their suppressive function, anti-PD-1 treatment may improve immune responses in the tumor microenvironment by inhibiting the function of Tregs [37, 38]. Here, PDCD1 is linked to neoplasm.